Docebo Inc.
DCBO
$17.19
-$0.45-2.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.65% | 11.87% | 13.16% | 15.11% | 16.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.65% | 11.87% | 13.16% | 15.11% | 16.79% |
| Cost of Revenue | 19.12% | 16.21% | 15.18% | 15.78% | 17.64% |
| Gross Profit | 11.10% | 10.84% | 12.68% | 14.95% | 16.59% |
| SG&A Expenses | 6.83% | 6.39% | 8.26% | 9.31% | 7.65% |
| Depreciation & Amortization | 28.12% | -5.85% | 5.86% | 4.15% | 3.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.85% | 10.05% | 12.24% | 13.05% | 12.41% |
| Operating Income | 33.18% | 29.89% | 22.87% | 44.63% | 110.12% |
| Income Before Tax | -5.22% | 3.09% | 27.08% | 13.29% | 165.85% |
| Income Tax Expenses | -716.17% | -332.25% | 89.73% | -153.96% | -239.86% |
| Earnings from Continuing Operations | 49.38% | 40.31% | 25.05% | 24.99% | 240.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.38% | 40.31% | 25.05% | 24.99% | 240.64% |
| EBIT | 33.18% | 29.89% | 22.87% | 44.63% | 110.12% |
| EBITDA | 25.18% | 21.23% | 12.76% | 29.12% | 74.00% |
| EPS Basic | 56.70% | 47.14% | 28.62% | 29.06% | 238.68% |
| Normalized Basic EPS | 0.85% | 8.88% | 38.33% | 23.97% | 114.69% |
| EPS Diluted | 58.18% | 48.51% | 29.18% | 29.49% | 250.52% |
| Normalized Diluted EPS | 0.82% | 8.87% | 38.37% | 24.30% | 116.25% |
| Average Basic Shares Outstanding | -4.91% | -3.15% | -3.26% | -3.83% | -5.31% |
| Average Diluted Shares Outstanding | -4.87% | -3.19% | -3.45% | -4.23% | -5.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |